199 related articles for article (PubMed ID: 23784081)
1. Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations.
Ingram N; Northwood EL; Perry SL; Marston G; Snowden H; Taylor JC; Scott N; Bishop DT; Coletta PL; Hull MA
Carcinogenesis; 2013 Oct; 34(10):2341-9. PubMed ID: 23784081
[TBL] [Abstract][Full Text] [Related]
2. Lack of interleukin-4 receptor alpha chain-dependent signalling promotes azoxymethane-induced colorectal aberrant crypt focus formation in Balb/c mice.
Ko CW; Cuthbert RJ; Orsi NM; Brooke DA; Perry SL; Markham AF; Coletta PL; Hull MA
J Pathol; 2008 Apr; 214(5):603-9. PubMed ID: 18220315
[TBL] [Abstract][Full Text] [Related]
3. Association study on IL-4, IL-4Rα and IL-13 genetic polymorphisms in Swedish patients with colorectal cancer.
Shamoun L; Skarstedt M; Andersson RE; Wågsäter D; Dimberg J
Clin Chim Acta; 2018 Dec; 487():101-106. PubMed ID: 30227113
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
Banday MZ; Sameer AS; Chowdri NA; Haq E
Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
[TBL] [Abstract][Full Text] [Related]
5. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression.
Nemati K; Golmoghaddam H; Hosseini SV; Ghaderi A; Doroudchi M
Gene; 2015 Apr; 561(1):88-94. PubMed ID: 25680555
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control Study.
Ankathil R; Mustapha MA; Abdul Aziz AA; Mohd Shahpudin SN; Zakaria AD; Abu Hassan MR; Musa KI
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1621-1632. PubMed ID: 31244280
[TBL] [Abstract][Full Text] [Related]
8. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
9. A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.
Bong YS; Assefnia S; Tuohy T; Neklason DW; Burt RW; Ahn J; Bueno De Mesquita PJ; Byers SW
Oncotarget; 2016 Dec; 7(49):80508-80520. PubMed ID: 27768599
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-13 and its signaling pathway is associated with obesity-related colorectal tumorigenesis.
Matsui S; Okabayashi K; Tsuruta M; Shigeta K; Seishima R; Ishida T; Kondo T; Suzuki Y; Hasegawa H; Shimoda M; Sugimoto S; Sato T; Kitagawa Y
Cancer Sci; 2019 Jul; 110(7):2156-2165. PubMed ID: 31099450
[TBL] [Abstract][Full Text] [Related]
11. Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc
Hull MA; Cuthbert RJ; Ko CWS; Scott DJ; Cartwright EJ; Hawcroft G; Perry SL; Ingram N; Carr IM; Markham AF; Bonifer C; Coletta PL
Sci Rep; 2017 Jul; 7(1):6074. PubMed ID: 28729694
[TBL] [Abstract][Full Text] [Related]
12. Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis.
Peignon G; Durand A; Cacheux W; Ayrault O; Terris B; Laurent-Puig P; Shroyer NF; Van Seuningen I; Honjo T; Perret C; Romagnolo B
Gut; 2011 Feb; 60(2):166-76. PubMed ID: 21205878
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-13/interleukin-4 receptor pathway is crucial for production of Sd
Tsubokawa D; Ishiwata K; Goso Y; Nakamura T; Hatta T; Ishihara K; Kanuka H; Tsuji N
Parasitol Int; 2017 Dec; 66(6):731-734. PubMed ID: 28802865
[TBL] [Abstract][Full Text] [Related]
14. An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk.
Schwartzbaum JA; Ahlbom A; Lönn S; Malmer B; Wigertz A; Auvinen A; Brookes AJ; Collatz Christensen H; Henriksson R; Johansen C; Salminen T; Schoemaker MJ; Swerdlow AJ; Debinski W; Feychting M
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2448-54. PubMed ID: 18006935
[TBL] [Abstract][Full Text] [Related]
15. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis.
Endo H; Hosono K; Uchiyama T; Sakai E; Sugiyama M; Takahashi H; Nakajima N; Wada K; Takeda K; Nakagama H; Nakajima A
Gut; 2011 Oct; 60(10):1363-71. PubMed ID: 21406387
[TBL] [Abstract][Full Text] [Related]
16. Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
[TBL] [Abstract][Full Text] [Related]
17. Increased proton-sensing receptor GPR4 signalling promotes colorectal cancer progression by activating the hippo pathway.
Yu M; Cui R; Huang Y; Luo Y; Qin S; Zhong M
EBioMedicine; 2019 Oct; 48():264-276. PubMed ID: 31530502
[TBL] [Abstract][Full Text] [Related]
18. Gavage of Fecal Samples From Patients With Colorectal Cancer Promotes Intestinal Carcinogenesis in Germ-Free and Conventional Mice.
Wong SH; Zhao L; Zhang X; Nakatsu G; Han J; Xu W; Xiao X; Kwong TNY; Tsoi H; Wu WKK; Zeng B; Chan FKL; Sung JJY; Wei H; Yu J
Gastroenterology; 2017 Dec; 153(6):1621-1633.e6. PubMed ID: 28823860
[TBL] [Abstract][Full Text] [Related]
19. Association of interleukin-17A polymorphisms with the risk of colorectal cancer: A case-control study.
Bedoui SA; Barbirou M; Stayoussef M; Dallel M; Mokrani A; Makni L; Mezlini A; Bouhaouala B; Yacoubi-Loueslati B; Almawi WY
Cytokine; 2018 Oct; 110():18-23. PubMed ID: 29689450
[TBL] [Abstract][Full Text] [Related]
20. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.
Grivennikov SI; Wang K; Mucida D; Stewart CA; Schnabl B; Jauch D; Taniguchi K; Yu GY; Osterreicher CH; Hung KE; Datz C; Feng Y; Fearon ER; Oukka M; Tessarollo L; Coppola V; Yarovinsky F; Cheroutre H; Eckmann L; Trinchieri G; Karin M
Nature; 2012 Nov; 491(7423):254-8. PubMed ID: 23034650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
